Seattle Needs to Stick to its Vision for Global Health, Recession or Not, Says Sen. Murray

Sen. Patty Murray is one of seven kids. While growing up, her dad was diagnosed with multiple sclerosis. It was hard for him to support a family, so Murray’s mother went on food stamps for a time. But no matter how rough times got, the family had a goal that all seven kids would graduate from college. They did.

Murray used this little anecdote yesterday to make a point to an audience of business leaders at the Seattle Chamber of Commerce’s annual leadership conference at Suncadia Resort in Roslyn, WA. Instead of making excuses or whining about the recession, people here in Seattle should keep their eyes on the prize, which is to turn the region into an even bigger hotspot for global health research and development than it already is.

“We did it because we had a goal,” Murray said of her family’s success.

The chamber’s leadership retreat brought together big-name speakers from the global health arena to help brainstorm a bit about ways that businesses, nonprofit organizations, and researchers can collaborate to put a dent in some of the health disparities that keep holding back poor countries. Judging from the question-and-answer sessions, the drumbeat of dire economic news was weighing pretty heavily on this audience. That’s what led Murray to urge the business leaders to stay focused.

There were quite a few other thought-provoking sessions from the morning sessions. Here are some highlights:

William Foege, a former director of the Centers for Disease Control and now a senior fellow at the Bill & Melinda Gates Foundation, got a standing ovation after he urged businesses to bring their expertise, time, and cash to the global health cause. As an example, he told the story of ivermectin (Mectizan), the drug Merck donated to cure river blindness in the developing world in the 1980s, after making its money on selling it as a product for dogs.

This wasn’t all about altruism for Merck, Foege said. The drug company found that the river blindness program motivated its employees, and helped Merck retain some of its brightest people, because they were proud to work there. (Nobody dared to ask out loud if this is really possible anymore, but since Merck announced 7,200 global layoffs the day before, including 300 in Seattle, I’m sure plenty of people were wondering.)

Foege wasn’t just scolding businesses, but urging everyone to set aside their preconceptions to work for global health. Nonprofit organizations need to recognize that corporations aren’t all evil, and that they have critical talents and products that nonprofits need to tackle these global health problems, he said. “We underestimate the amount of altruism in corporations, just as we underestimate the amount of greed in church workers, public servants, and public health workers,” Foege said.

—Sometimes the enormity of these problems get lost in statistics, but yesterday one man’s story drove home how huge these problems are. Jackson Orem, a physician at the Uganda Cancer Institute, traveled to the conference as part of his collaboration with Corey Casper and colleagues at the Seattle-based Fred Hutchinson Cancer Research Center. Until September, Orem was the only full-time oncologist in Uganda, a country with 30 million people.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.